142 related articles for article (PubMed ID: 32140783)
1. Role of susceptibility-weighted imaging and intratumoral susceptibility signals in grading and differentiating pediatric brain tumors at 1.5 T: a preliminary study.
Gaudino S; Marziali G; Pezzullo G; Guadalupi P; Giordano C; Infante A; Benenati M; Ramaglia A; Massimi L; Gessi M; Frassanito P; Caldarelli M; Colosimo C
Neuroradiology; 2020 Jun; 62(6):705-713. PubMed ID: 32140783
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of grade II/III and grade IV glioma by combining "T1 contrast-enhanced brain perfusion imaging" and susceptibility-weighted quantitative imaging.
Saini J; Gupta PK; Sahoo P; Singh A; Patir R; Ahlawat S; Beniwal M; Thennarasu K; Santosh V; Gupta RK
Neuroradiology; 2018 Jan; 60(1):43-50. PubMed ID: 29090331
[TBL] [Abstract][Full Text] [Related]
3. Quantitative vs. semiquantitative assessment of intratumoral susceptibility signals in patients with different grades of glioma.
Bhattacharjee R; Gupta RK; Patir R; Vaishya S; Ahlawat S; Singh A
J Magn Reson Imaging; 2020 Jan; 51(1):225-233. PubMed ID: 31087724
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility-Weighted Imaging of Glioma: Update on Current Imaging Status and Future Directions.
Hsu CC; Watkins TW; Kwan GN; Haacke EM
J Neuroimaging; 2016 Jul; 26(4):383-90. PubMed ID: 27227542
[TBL] [Abstract][Full Text] [Related]
5. Diffusion-weighted MRI combined with susceptibility-weighted MRI: added diagnostic value for four common lateral ventricular tumors.
Yu Y; Zhang H; Xiao Z; She D; Xing Z; Yang X; Cao D
Acta Radiol; 2018 Aug; 59(8):980-987. PubMed ID: 29065704
[TBL] [Abstract][Full Text] [Related]
6. Glioma grading by microvascular permeability parameters derived from dynamic contrast-enhanced MRI and intratumoral susceptibility signal on susceptibility weighted imaging.
Li X; Zhu Y; Kang H; Zhang Y; Liang H; Wang S; Zhang W
Cancer Imaging; 2015 Mar; 15(1):4. PubMed ID: 25889239
[TBL] [Abstract][Full Text] [Related]
7. Intergrating conventional MRI, texture analysis of dynamic contrast-enhanced MRI, and susceptibility weighted imaging for glioma grading.
Su CQ; Lu SS; Han QY; Zhou MD; Hong XN
Acta Radiol; 2019 Jun; 60(6):777-787. PubMed ID: 30244590
[TBL] [Abstract][Full Text] [Related]
8. Multi-parametric effect in predicting tumor histological grade by using susceptibility weighted magnetic resonance imaging in tongue squamous cell carcinoma.
Yang X; Zhu J; Dai Y; Tian Z; Yang G; Shi H; Wu Y; Tao X
BMC Med Imaging; 2019 Mar; 19(1):24. PubMed ID: 30866854
[TBL] [Abstract][Full Text] [Related]
9. Combined value of susceptibility-weighted and perfusion-weighted imaging in assessing who grade for brain astrocytomas.
Wang XC; Zhang H; Tan Y; Qin JB; Wu XF; Wang L; Zhang L
J Magn Reson Imaging; 2014 Jun; 39(6):1569-74. PubMed ID: 24987755
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Value of Fractal Analysis for the Differentiation of Brain Tumors Using 3-Tesla Magnetic Resonance Susceptibility-Weighted Imaging.
Di Ieva A; Le Reste PJ; Carsin-Nicol B; Ferre JC; Cusimano MD
Neurosurgery; 2016 Dec; 79(6):839-846. PubMed ID: 27332779
[TBL] [Abstract][Full Text] [Related]
11. Grading of IDH-mutant astrocytoma using diffusion, susceptibility and perfusion-weighted imaging.
Yang X; Xing Z; She D; Lin Y; Zhang H; Su Y; Cao D
BMC Med Imaging; 2022 May; 22(1):105. PubMed ID: 35644621
[TBL] [Abstract][Full Text] [Related]
12. Differentiating intracranial solitary fibrous tumor/hemangiopericytoma from meningioma using diffusion-weighted imaging and susceptibility-weighted imaging.
Chen T; Jiang B; Zheng Y; She D; Zhang H; Xing Z; Cao D
Neuroradiology; 2020 Feb; 62(2):175-184. PubMed ID: 31673748
[TBL] [Abstract][Full Text] [Related]
13. Added value and diagnostic performance of intratumoral susceptibility signals in the differential diagnosis of solitary enhancing brain lesions: preliminary study.
Kim HS; Jahng GH; Ryu CW; Kim SY
AJNR Am J Neuroradiol; 2009 Sep; 30(8):1574-9. PubMed ID: 19461062
[TBL] [Abstract][Full Text] [Related]
14. Role of Dynamic Contrast-Enhanced Perfusion Magnetic Resonance Imaging in Grading of Pediatric Brain Tumors on 3T.
Gupta PK; Saini J; Sahoo P; Patir R; Ahlawat S; Beniwal M; Thennarasu K; Santosh V; Gupta RK
Pediatr Neurosurg; 2017; 52(5):298-305. PubMed ID: 28848203
[TBL] [Abstract][Full Text] [Related]
15. Semiquantitative assessment of intratumoral susceptibility signals using non-contrast-enhanced high-field high-resolution susceptibility-weighted imaging in patients with gliomas: comparison with MR perfusion imaging.
Park MJ; Kim HS; Jahng GH; Ryu CW; Park SM; Kim SY
AJNR Am J Neuroradiol; 2009 Aug; 30(7):1402-8. PubMed ID: 19369602
[TBL] [Abstract][Full Text] [Related]
16. [Study of susceptibility weighted imaging on MR and pathologic findings to distinguish benign or malignant soft tissue tumor].
Liu J; Chen Y; Bao XM; Ling XL; Ding JP; Zhang ZK
Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):350-354. PubMed ID: 28535651
[No Abstract] [Full Text] [Related]
17. Non-invasive assessment of intratumoral vascularity using arterial spin labeling: A comparison to susceptibility-weighted imaging for the differentiation of primary cerebral lymphoma and glioblastoma.
Furtner J; Schöpf V; Preusser M; Asenbaum U; Woitek R; Wöhrer A; Hainfellner JA; Wolfsberger S; Prayer D
Eur J Radiol; 2014 May; 83(5):806-10. PubMed ID: 24613549
[TBL] [Abstract][Full Text] [Related]
18. High intratumoral susceptibility signal grade on susceptibility-weighted imaging: a risk factor for hemorrhage after stereotactic biopsy.
Tanji M; Mineharu Y; Sakata A; Okuchi S; Fushimi Y; Oishi M; Terada Y; Sano N; Yamao Y; Arakawa Y; Yoshida K; Miyamoto S
J Neurosurg; 2023 Jan; 138(1):120-127. PubMed ID: 35561695
[TBL] [Abstract][Full Text] [Related]
19. Contrast Leakage Patterns from Dynamic Susceptibility Contrast Perfusion MRI in the Grading of Primary Pediatric Brain Tumors.
Ho CY; Cardinal JS; Kamer AP; Lin C; Kralik SF
AJNR Am J Neuroradiol; 2016 Mar; 37(3):544-51. PubMed ID: 26564438
[TBL] [Abstract][Full Text] [Related]
20. The diagnostic value of postcontrast susceptibility-weighted imaging in the assessment of intracranial brain neoplasm at 3T.
Kang H; Jang S
Acta Radiol; 2021 Jun; 62(6):791-798. PubMed ID: 32664747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
